IS
MDMA REALLY NEUROTOXIC?
There is still
controversy about whether MDMA causes long-term damage to serotonin neurons, a concern that
arose from previous experience with
similar amphetamine-like serotonin-releasing drugs. Other drugs that release both dopamine and serotonin (methamphetamine, for example) have been shown in
laboratory studies to cause long-lasting changes in either (or both) dopamine or serotonin neurons in the brain. None of the usual contents of the ends of the serotonin
neurons that normally release
serotonin onto the neuron's receptors (nerve terminals) can be detected. The serotonin itself, the serotonin
transporter, and other components of
the terminal are decreased markedly. With almost all of these drugs, the amount of damage is dose- and
time-related. Small doses produce
little or no damage; moderate doses produce marked decreases in
serotonin
indices but leave the serotonin system still functional; and
large doses can eliminate the ability of these
neurons to release
serotonin for months.
MDIVIA acts like other
drugs in the same class. In experimental studies in rats and primates, MDMA produced temporary loss of serotonin, which doesn't present
any real long-term problem but may be responsible for the midweek blues. It also produces the same
kind of long-term changes that the
other amphetamine-like drugs produce. With some dose regimens, a limited amount
of recovery occurred, while with higher dose regimens, no recovery occurred. One of the controversies about MDMA is whether the loss of these markers really means
that the nerve endings are gone or
just depleted of their contents. None of the studies conducted so far provide incontrovertible proof that the
nerve endings are gone or not.
However, there is little question that at the very least, the serotonin itself,
the transporter, and the main synthetic enzyme are reduced to very low levels for a long time after repeated, heavy
exposure to MDMA. In any case, the
serotonin neuron is not capable of functioning normally, and so it may be a moot point if the terminal is
there and devoid of contents or
actually gone. How much MDMA is necessary to produce significant long-term damage? The dose range that
produced permanent damage in
experiments with squirrel monkeys was about the equivalent of a 150- pound person taking 350 milligrams spaced over
four days. Earlier studies showed
that this occurred when the drug
was administered by injection in the
monkeys, but more recent studies using oral administration, resembling the way that humans take the
drug, report similar results. An
average human dose of Ecstasy is about 100 milligrams.
Does the same type of
damage happen in people who take high doses of MDMA for a long time? An increasing number of studies suggest that the answer is yes. Numerous studies show that levels
of major serotonin
markers like the serotonin transporter or the main
metabolite of sero‑
tonin in the nervous system are suppressed in
Ecstasy users. None of
these
studies is perfect anti the debate continues, but the evidence is
mounting that long-term decreases in serotonin
neuron function occur in
heavy MDMA users (people who use a hundred times
or more over sev‑
eral years). We don't know if these effects
reverse if someone stops using
MDMA, although some studies indicate that this
might be so.
What are the long-term
effects of this type of
serotonin loss? Are some of the
anxiety and learning disorders that we discussed caused by this type of damage? Residual anxiety and irritability/hostility have been reported
in a number of heavy Ecstasy users. Because increased levels of serotonin have been associated with improved mood
(see the "Hallucinogens"
chapter), and its loss with depression in some cases, it is not unreasonable to speculate that mood disorders might be
in the future for heavy
Ecstasy users.